Jinhai Medical Technology's 2025 Loss Narrows; Shares Drop 12%

MT Newswires Live03-30

Jinhai Medical Technology (HKG:2225) booked SG$17.1 million in attributable loss for 2025, narrowing from SG$18.0 million in 2024, according to a Hong Kong bourse filing Friday.

Shares of the healthcare and construction outsourcing firm fell over 12% in morning trade Monday.

Loss per share was SG$0.0033, compared with SG$0.0035 in the prior year.

Revenue fell to SG$46.3 million from SG$50.2 million in 2024.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment